Matches in UGent Biblio for { <https://biblio.ugent.be/publication/3256661#aggregation> ?p ?o. }
Showing items 1 to 35 of
35
with 100 items per page.
- aggregation classification "A1".
- aggregation creator B469741.
- aggregation creator person.
- aggregation creator person.
- aggregation creator person.
- aggregation creator person.
- aggregation date "2013".
- aggregation format "application/pdf".
- aggregation hasFormat 3256661.bibtex.
- aggregation hasFormat 3256661.csv.
- aggregation hasFormat 3256661.dc.
- aggregation hasFormat 3256661.didl.
- aggregation hasFormat 3256661.doc.
- aggregation hasFormat 3256661.json.
- aggregation hasFormat 3256661.mets.
- aggregation hasFormat 3256661.mods.
- aggregation hasFormat 3256661.rdf.
- aggregation hasFormat 3256661.ris.
- aggregation hasFormat 3256661.txt.
- aggregation hasFormat 3256661.xls.
- aggregation hasFormat 3256661.yaml.
- aggregation isPartOf urn:issn:1434-193X.
- aggregation language "eng".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Chemistry".
- aggregation title "Synthesis of 2-ethyl-19-nor analogs of 1α,25-dihydroxyvitamin D₃".
- aggregation abstract "The synthesis of two new A-ring precursors, useful for the convergent assembly of 2α-ethyl and 2β-ethyl derivatives of 19-nor-1α,25-dihydroxyvitamin D3, is described. These building blocks were prepared in 14 steps from quinic acid, which led to a new and practical synthesis of 2α-ethyl-14-epi-19-nor-20-epi-23-yne-1,25(OH)2D3, an analog that shows a remarkably low calcemic effect in mice, while retaining the ability to promote cell differentiation and to inhibit cell proliferation in a number of human cancer cell lines.".
- aggregation authorList BK808193.
- aggregation endPage "735".
- aggregation issue "4".
- aggregation startPage "728".
- aggregation aggregates 4345593.
- aggregation isDescribedBy 3256661.
- aggregation similarTo ejoc.201201261.
- aggregation similarTo LU-3256661.